Based on the above discussion, we believe our findings have an excellent clinical potential  as amoxicillin treatment in metabolic syndrome pathophysiology  could improve host insulin signalling, leading to a decrease in blood glucose level. This evidence concerns the gene INS and metabolic syndrome.